Fábio Pittella Silva

University of Brasilia

H指数:19

被引数:2,139

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrative Analysis Uncovers SETD5 as an Epigenetic Regulator of Transcriptional and Immune Tumor Programs Across Human Cancers

整合分析揭示SETD5作为转录和免疫肿瘤程序的人类癌症表观遗传调控因子

Current Issues in Molecular Biology

IF3

2026-07-230

Central-metal effect on anticancer activity and molecular docking of Co(II), Ni(II), and Zn(II) complexes with isatin-based ligand

基于异烟酸配体的Co(II)、Ni(II)和Zn(II)配合物的中心金属效应对抗肿瘤活性和分子对接的影响

Journal of Molecular Structure

IF4.7

2026-04-260

PRE

Machine Learning Radiomics in Computed Tomography for Prediction of Tumor and Nodal Stages in Colorectal Cancer

计算机断层扫描中的机器学习放射组学预测结直肠癌的肿瘤和淋巴结分期

Cancers

IF4.4

2026-01-260

OAAI

Breakthroughs in the nanoparticle-mediated delivery of siRNA for breast cancer treatment

纳米颗粒介导的siRNA递送在乳腺癌治疗中的突破

Nanomedicine

IF3.9

2025-10-090

PRE

Advancing Leukemia Management Through Liquid Biopsy: Insights into Biomarkers and Clinical Utility

通过液体活检推进白血病管理：对生物标志物和临床应用价值的见解

CANCERS

IF4.4

2025-04-250

GLP and G9a histone methyltransferases as potential therapeutic targets for lymphoid neoplasms

CANCER CELL INTERNATIONAL

IF6

2024-07-120

OAAI

Structural Design, Anticancer Evaluation, and Molecular Docking of Newly Synthesized Ni(II) Complexes with ONS-Donor Dithiocarbazate Ligands

MOLECULES

IF4.6

2024-06-101

OAAI

Circulating tumor DNA as a potential indicator of treatment response in patients with surgically unresectable PDAC

CANCER RESEARCH

IF16.6

2024-03-220

PRE

SETD4 transcription levels correlates with leukemic burden and SMYD2 transcription in acute lymphoblastic leukemia

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Dithiocarbazate ligands and their Ni(II) complexes with potential biological activity: Structural, antitumor and molecular docking study

具有潜在生物活性的二硫代氨基甲酸配体及其Ni(II) 配合物: 结构，抗肿瘤和分子对接研究

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2023-03-074

OAAI

Targeting DNA Methylation as an Epigenetic Leukocyte Counting Tool

CLINICAL CHEMISTRY

IF6.3

2022-03-120

Analysis of plasma and serum as a source of circulating tumor DNA for hotspot mutations detection in liquid biopsy

CANCER RESEARCH

IF16.6

2020-08-150

PRE

Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?

CLINICAL CHEMISTRY

IF6.3

2020-06-0952

OAAI

The dynamic conformational landscape of the protein methyltransferase SETD8

ELIFE

IF0

2019-05-1337

Using cancer-associated variants to dissect functions of SETD8

CANCER RESEARCH

IF16.6

2018-07-010

PRE

Association of MLL2/KMT2D and MLL3/KMT2C with chronic myeloid leukemia

CANCER RESEARCH

IF16.6

2018-07-010

PRE

GLP overexpression is associated with poor prognosis in Chronic Lymphocytic Leukemia and its inhibition induces leukemic cell death

INVESTIGATIONAL NEW DRUGS

IF2.7

2018-05-3112

PREAI

MLL2/KMT2D and MLL3/KMT2C expression correlates with disease progression and response to imatinib mesylate in chronic myeloid leukemia

CANCER CELL INTERNATIONAL

IF6

2018-02-2024

OAAI

A panel of markers for identification of malignant and non-malignant cells in culture from effusions

ONCOLOGY REPORTS

IF3.9

2017-10-119

OAAI

Bioorthogonal Profiling of Protein Methylation (BPPM) identified MCM5 as a new substrate for SETD8 in DNA replication

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Fábio Pittella Silva

个人简介

教育背景

工作经历

荣誉奖项

研究方向